This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Formed in 2007 by the merger of the Chicago Mercantile Exchange (CME) and the Chicago Board of Trade (CBOT), CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. The Chicago Mercantile Exchange was originally formed as a non-profit organization in 1898, but was converted to a for-profit company in 2000. It became the first publicly traded financial exchange in the U.S. in Dec 2002. CBOT, established in 1848, is a leading futures and options exchange. In Apr 2005, CBOT converted into a for-profit stock-based holding company and for-profit membership exchange subsidiary.
CME (CME) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for CME (CME) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CME Group (CME) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 2.54% and 1.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
CME Group's (CME) Q1 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services.
Don't Ignore the Relative Strength of These 3 Finance Stocks
by Derek Lewis
While many finance-related stocks have come under pressure following banking concerns, all three of these have displayed relative strength.
Here's How Much a $1000 Investment in CME Group Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Nasdaq (NDAQ) Q1 Earnings Top Estimates, Revenues Increase Y/Y
by Zacks Equity Research
Nasdaq's (NDAQ) first-quarter 2023 results reflect organic growth and solid segmental performance.
CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Reasons Why CME Group (CME) Stock is an Attractive Pick
by Zacks Equity Research
CME Group (CME) stands to gain from market data distribution channels, higher custody fees and prudent capital deployment.
Will CME (CME) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cboe Global (CBOE) Up 16.5% in a Year: Will the Rally Last?
by Zacks Equity Research
Cboe Global (CBOE) stock rallies on the back of strong market position, global reach, higher logical port fees and physical port fees, favorable growth estimates and solid capital position.
What Makes CME (CME) a New Buy Stock
by Zacks Equity Research
CME (CME) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Top Analyst Reports for Chevron, Coca-Cola & General Electric
by Santanu Roy
Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), The Coca-Cola Company (KO) and General Electric Company (GE).
Why Is CME (CME) Down 3% Since Last Earnings Report?
by Zacks Equity Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Hold is an Apt Strategy for CME Group (CME) Stock
by Zacks Equity Research
CME Group (CME) is poised to grow, given its market data distribution channels, higher custody fees and prudent capital deployment.
Zacks Industry Outlook Highlights CME Group, Cboe Global Markets, Nasdaq, MarketAxess Holdings and Coinbase Global
by Zacks Equity Research
CME Group, Cboe Global Markets, Nasdaq, MarketAxess Holdings and Coinbase Global are part of the Zacks Industry Outlook article.
5 Stocks to Watch From the Prospering Securities and Exchanges Industry
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CME, CBOE, NDAQ, MKTX and COIN. However, compliance with regulations remains a challenge.
CME Group (CME) Q4 Earnings Top on Higher Trading Volume
by Zacks Equity Research
CME Group (CME) Q4 results reflect higher revenues, driven by increased trading volume.
CME Group (CME) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 1.05% and 0.23%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Will CME Group (CME) Keep Its Beat Streak Alive in Q4 Earnings?
by Zacks Equity Research
CME Group's (CME) Q4 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.
CBOE Global (CBOE) Q4 Earnings Top Estimates
by Zacks Equity Research
CBOE (CBOE) delivered earnings and revenue surprises of 1.69% and 0.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Awaits Intercontinental (ICE) This Earnings Season?
by Zacks Equity Research
Intercontinental's (ICE) fourth-quarter results are likely to reflect solid performance at Exchanges and Fixed Income and Data Services segments.
What's in the Cards for Cboe Global (CBOE) in Q4 Earnings?
by Zacks Equity Research
Cboe Global's (CBOE) fourth-quarter results are likely to reflect higher volumes across businesses, higher logical port fees, and contribution from acquisitions as well as from strong proprietary products.